Folic acid supplementation doesn't boost cancer risk, analysis finds

01/28/2013 | Reuters

An examination of 13 trials involving nearly 50,000 individuals found no significant difference in the incidence of cancer between those who received folic acid supplements for five years and those who took placebos. Folic acid was not associated with a greater likelihood of developing certain types of cancer, either, including cancers of the colon, prostate, lung or breast. The findings were published in The Lancet.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
FDA/Device Technology Attorney
Quarles & Brady
Washington, DC
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Executive Medical Director
Aspirus Network Inc
Wausau, WI
Medical Director - Cataract
Abbott
Santa Ana, CA